Brain blood flow and sugar study for Alzheimer's and diabetes
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study uses brain scans to see how blood flow and sugar transport work in people with both Alzheimer's disease and type 2 diabetes. It may help doctors understand how these conditions interact and find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have suspected Alzheimer's disease
- You have type 2 diabetes (for one of the study groups)
- You are able and willing to follow the study procedures
- You do not have any other significant brain disease besides dementia
- You are not receiving active cancer treatment
- You have no history of alcohol or drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how reliable a brain scan called [15O]H2O-PET is for measuring blood flow. It aims to improve our understanding of brain health in people over 60 without diabetes.
This study tests a new way to measure how the brain uses sugar (glucose) to see if the hormone glucagon affects it. It may help researchers understand how certain hormones work in the body.
This study uses brain imaging to measure two things in the brain—amyloid protein and how the brain uses sugar. It may help researchers better understand early brain changes in people in the ALFA project.
This study uses PET/CT/MRI imaging to look for brain “imaging biomarkers” in people across the Alzheimer’s disease range. It may help researchers better understand how Alzheimer’s changes the brain over time and improve future treatments.
This study uses special MRI scans and a PET scan to look at brain chemistry and sugar use in Alzheimer's disease, frontotemporal dementia, and healthy volunteers. The goal is to find better ways to tell these conditions apart.
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
Hear when a new Alzheimer Dementia (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.